Cargando…

Analyzing safety and effectiveness of Mavacamten in comparison with placebo for managing hypertrophic cardiomyopathy: a systemic review and meta-analysis

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a hereditary myocardial disorder, often due to sarcomere gene mutations, characterized by the left ventricular hypertrophy. Current treatments offer symptomatic relief but lack specificity. Mavacamten, an allosteric inhibitor, has shown significant im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rangwala, Hussain Sohail, Fatima, Hareer, Ali, Mirha, Ahmed, Syed Taha, Rangwala, Burhanuddin Sohail, Abbas, Syed Raza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693538/ https://www.ncbi.nlm.nih.gov/pubmed/38041770 http://dx.doi.org/10.1186/s43044-023-00427-5

Ejemplares similares

Ultrasound renal denervation: the future of hypertension management?
por: Ali, Laiba, et al.
Publicado: (2023)

Assessment Precision of CT Perfusion Imaging in the Detection of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Mubarak, Fatima, et al.
Publicado: (2023)

Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
por: Fatima, Hareer, et al.
Publicado: (2023)

Rising HIV cases in Pakistan: Start of a pandemic?
por: Rangwala, Hussain Sohail, et al.
Publicado: (2022)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
por: Dong, Tiffany, et al.
Publicado: (2023)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023)

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review
por: Edelberg, Jay M., et al.
Publicado: (2022)

Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis
por: Memon, Areeba, et al.
Publicado: (2023)

Viewing the Brain Through Retina: A New Avenue for Early Diagnosis of Alzheimer’s Disease
por: Zuhair, Varisha, et al.
Publicado: (2023)

Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy and the impact of mavacamten
por: Mathai, Susan, et al.
Publicado: (2022)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials
por: Rabiee Rad, Mehrdad, et al.
Publicado: (2023)

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
por: DeVries, J Hans, et al.
Publicado: (2023)

Considerations for managed care pharmacy in evaluating mavacamten, a novel agent for obstructive hypertrophic cardiomyopathy
por: Taddei-Allen, Patty
Publicado: (2022)

Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial
por: Tian, Zhuang, et al.
Publicado: (2023)

Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM)
por: Langley, Paul C
Publicado: (2022)

Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment
por: Wang, Kai, et al.
Publicado: (2023)

Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca(2+) flux caused by thin filament hypertrophic cardiomyopathy mutations
por: Sparrow, Alexander J., et al.
Publicado: (2020)

Mavacamten for hypertrophic cardiomyopathy: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
por: Beinfeld, Molly, et al.
Publicado: (2022)

Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy
por: Tian, Zhuang, et al.
Publicado: (2023)

Mavacamten: First Approval
por: Keam, Susan J.
Publicado: (2022)

Correction to: Mavacamten: First Approval
por: Keam, Susan J.
Publicado: (2022)

Recently FDA-approved drug: A new hope for vitiligo patients?
por: Siddiq, Mohammad Arham, et al.
Publicado: (2022)

Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin
por: Shafique, Muhammad Ashir, et al.
Publicado: (2023)

Effects of omecamtiv mecarbil and mavacamten in isolated human atrium
por: Abella, Lina Maria Rayo, et al.
Publicado: (2022)

Theory and practice in gas turbines
por: Rangwala, A S
Publicado: (2014)

Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Cancer Stem Cells: Repair Gone Awry?
por: Rangwala, Fatima, et al.
Publicado: (2011)

Apical Hypertrophic Cardiomyopathy: A Case Report
por: Abugroun, Ashraf, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Building multiclass classifiers for remote homology detection and fold recognition
por: Rangwala, Huzefa, et al.
Publicado: (2006)

Evaluation of short read metagenomic assembly
por: Charuvaka, Anveshi, et al.
Publicado: (2011)

Lasing by driven atoms-cavity system in collective strong coupling regime
por: Sawant, Rahul, et al.
Publicado: (2017)

Safety Monitoring for Obstructive Hypertrophic Cardiomyopathy During Exercise
por: Nakayama, Atsuko, et al.
Publicado: (2020)

Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy
por: Chen, Chris, et al.
Publicado: (2023)

A Profile of Cases of Gestational Trophoblastic Neoplasia at a Large Tertiary Centre in Dubai
por: Rangwala, Tasneem H., et al.
Publicado: (2011)

IDMIL: an alignment-free Interpretable Deep Multiple Instance Learning (MIL) for predicting disease from whole-metagenomic data
por: Rahman, Mohammad Arifur, et al.
Publicado: (2020)

Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited via inotropic effectors
por: Ma, Weikang, et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_llun2gjis15fb7ed7dm8hdjrst